Panel Discussion: Discussing the Current Status of Neuroinflammatory Biomarkers & Existing Obstacles to Overcome in Neuroimmunology

Time: 3:30 pm
day: Day One


• Outlining the challenges of using fluid and CSF biomarkers to determine efficacy against neuroinflammation from remote sites of action

• Discussing emerging and established imaging tools for neuroinflammation in neurological indications

• Explaining the need for longitudinal samples to assist in biomarker validation and reliability in the clinic

• How does the recent accepted use of NfL as a surrogate endpoint in ALS impact the neuroimmunology field?